EpiVax - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $117,181.26 +4.17%
Ethereum $2,962.78 +5.73%
BNB $689.06 +2.88%
Optimism $0.68 +14.77%
Arbitrum $0.41 +14.09%
Solana $162.24 +2.96%
Polygon $0.22 +2.77%
Cosmos $4.72 +9.33%
Avalanche $21.08 +7.56%

Bitcoin $117,181.26 +4.17%
Ethereum $2,962.78 +5.73%
BNB $689.06 +2.88%
Optimism $0.68 +14.77%
Arbitrum $0.41 +14.09%
Solana $162.24 +2.96%
Polygon $0.22 +2.77%
Cosmos $4.72 +9.33%
Avalanche $21.08 +7.56%

EpiVax

company

Summary
Funding Rounds
Investors

About

EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.

11 - 50

Highlights

Total Funding Amount

Details

Last Funding Type: Grant
Last Funding Money Raised: $300K
Industries: Analytics,Biotechnology,Health Care,Pharmaceutical
Founded date: Jan 1, 1998
Number Of Employee: 11 - 50
Operating Status: Active

EpiVax is an immunology company and has developed comprehensive analytical capabilities in the field of computational immunology.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

7

$4.21M

EpiVax has raised a total of $4.21M in funding over 2 rounds. Their latest funding was raised on Sep 12, 2016 from a Grant round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Sep 12, 2016	Grant	$600K	1	National Institutes of Health	—	Detail
Sep 5, 2012	Grant	$300K	1	National Institutes of Health	—	Detail
Apr 9, 2012	Grant	$1.50M	1	—	—	Detail
Jan 25, 2011	Grant	$458K	1	—	—	Detail
Nov 26, 2008	Grant	$390K	1	—	—	Detail

Show More

Investors

Number of Lead Investors

Number of Investors

2

1

EpiVax is funded by 1 investors. National Institutes of Health are the most recent investors.

Investor Name	Lead Investor	Funding Round
National Institutes of Health	Yes	Grant